{
  "docId": "019de072-4b47-73db-b658-db74b88c61ed",
  "docSlug": "479ed371379fcba7e292c76acd5b0af7",
  "documentTitle": "BioNTech | Results Presentation Deck | 37 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 33,
  "pageCount": 37,
  "prevPage": 32,
  "nextPage": 34,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-4b47-73db-b658-db74b88c61ed/33",
  "deckHref": "/decks/019de072-4b47-73db-b658-db74b88c61ed",
  "deckJsonHref": "/decks/019de072-4b47-73db-b658-db74b88c61ed.json",
  "deckAnchorHref": "/decks/019de072-4b47-73db-b658-db74b88c61ed#slide-33",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.32,
        "x": 0.04,
        "y": 0.21
      },
      "kind": "list",
      "text": "1. Continued COVID-19 vaccine franchise leadership\n2. Further pipeline expansion & acceleration\n3. Global footprint & organization\n4. Corporate Development",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "989c403c-9d3d-44ff-ae5f-c850a04c6d49",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.58,
        "x": 0.38,
        "y": 0.39
      },
      "kind": "paragraph",
      "text": "Expect data updates for up to 3 additional pipeline programs. Global Development Organization transformation underway to support pipeline expansion and potential initiation of registration trials.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0c4dee17-a063-4382-be09-49c1210f96e1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.58,
        "x": 0.38,
        "y": 0.73
      },
      "kind": "paragraph",
      "text": "New partnerships & M&A to accelerate and enable long-term strategy. Extend mRNA platform into new “white spaces” and further expand toolkit in synthetic biology following collaborations with Medigene and Crescendo.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "40ab8ea2-c7b9-41f7-a7d4-eeaf9723bf94",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.58,
        "x": 0.38,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "Multiple data read-outs expected throughout the year. On track to submit regulatory data package for Omicron-adapted vaccine pending decision from regulators.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5131d740-fed2-4440-93b6-8902ac093e2c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.58,
        "x": 0.38,
        "y": 0.56
      },
      "kind": "paragraph",
      "text": "Expanding footprint in Europe, U.S., Asia, and Africa. Investing to expand global mRNA manufacturing capacity with new production nodes – including deployment of our first BioNTainer.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e7a9e59d-e3d0-4a86-baa0-317a2d423244",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.24,
        "x": 0.04,
        "y": 0.09
      },
      "kind": "title",
      "text": "Outlook for 2022",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8d730819-f950-4505-a72e-c7dbcd6c6c7a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 35,
      "from": 33,
      "beatId": "a49a57c0-328d-491b-8c30-ecc6a93f915f",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Visualization",
      "beatSlug": "monroes-sequence-visualization",
      "evidence": "The presentation outlines the company's outlook and expected pipeline milestones for 2022",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}